Duration of Antihistamine Treatment for Chronic Urticaria

Treatment Duration Framework

The American Academy of Allergy, Asthma, and Immunology recommends that antihistamines should be continued indefinitely in chronic urticaria until complete disease control is achieved for at least 3 consecutive months, at which point careful step-down can be attempted—but treatment duration is ultimately determined by disease activity rather than a fixed time period 1, 2
The initial treatment phase should start with standard-dose second-generation H1-antihistamines and assess response after 2-4 weeks, with the option to increase the dose up to 4-fold the standard dose if inadequate control is achieved 1, 2
Patients must achieve at least 3 consecutive months of complete disease control before attempting any dose reduction, and when stepping down, reduce the daily dose by no more than 1 tablet per month 1, 2
The Urticaria Control Test (UCT) score should be used to guide the "as much as needed and as little as possible" approach, with complete control defined as UCT >16 1, 2

Approximately 50% of patients with chronic urticaria presenting with wheals alone achieve remission by 6 months, while patients with both wheals and angioedema have a significantly worse prognosis, with over 50% still having active disease after 5 years 3, 4
Many patients will require antihistamine therapy for months to years, not weeks, due to the natural history of the disease 3, 4

If standard and high-dose antihistamines (up to 4x standard dose) fail to control symptoms, add omalizumab 300mg every 4 weeks, allowing up to 6 months for full response assessment 1, 2
If omalizumab fails, consider cyclosporine up to 5mg/kg body weight 1, 2